Nomura Holdings’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,000
Closed -$937K 1999
2025
Q3
$937K Sell
15,000
-73,800
-83% -$4.01M ﹤0.01% 1416
2025
Q2
$4.62M Buy
88,800
+73,800
+492% +$3.3M 0.01% 597
2025
Q1
$639K Sell
15,000
-63,900
-81% -$2.76M ﹤0.01% 1410
2024
Q4
$2.41M Sell
78,900
-25,000
-24% -$703K ﹤0.01% 1046
2024
Q3
$2.38M Buy
103,900
+25,000
+32% +$708K 0.01% 887
2024
Q2
$2.28M Buy
78,900
+21,200
+37% +$494K ﹤0.01% 906
2024
Q1
$1.19M Sell
57,700
-45,700
-44% -$980K ﹤0.01% 1046
2023
Q4
$2.8M Buy
+103,400
New +$2.71M 0.01% 861

Other funds holding GH

Nomura Holdings's GH Position: Q4 2025 in Review

Nomura Holdings sold out of Guardant Health (GH) in Q4 2025, closing a stake of 15,542 shares — an estimated $971K sold.

Nomura Holdings first reported a position in GH in Q4 2020 and held it in 4 quarters. The position peaked at $2.19M in Q4 2020. 496 funds tracked by Wall St. Rank hold GH as of Q4 2025.

  • Nomura Holdings reported no remaining Guardant Health position as of Q4 2025 after selling out during the quarter.
  • Nomura Holdings sold 15,542 Guardant Health shares in Q4 2025, an estimated $971K.
  • Nomura Holdings first reported a position in Guardant Health in Q4 2020 and held it in 4 quarters.
  • Nomura Holdings's Guardant Health position peaked at $2.19M in Q4 2020.
  • 496 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on Nomura Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.